Platinum containing anticancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells HT29 Cells HeLa Cells MCF-7 Cells Cell Line Kidney HL-60 Cells Hep G2 Cells Maxillary Artery KB Cells

Organisms4

Mice, Nude Mice, Inbred BALB C Oplopanax Mice, SCID

Diseases25

Ovarian Neoplasms Neoplasms Leukemia L1210 Neoplasms, Glandular and Epithelial Lung Neoplasms Intracranial Aneurysm Carcinoma, Non-Small-Cell Lung Colonic Neoplasms Breast Neoplasms Adenocarcinoma Neoplasms, Experimental Leukemia P388 Carcinoma Cystadenocarcinoma, Serous Peritoneal Neoplasms Fallopian Tube Neoplasms Prostatic Neoplasms Leukopenia Head and Neck Neoplasms Carcinoma, Squamous Cell Melanoma, Experimental Neoplasm Recurrence, Local Drug Hypersensitivity Neoplasm Metastasis Carcinoma, Small Cell

Chemicals and Drugs110

Platinum Compounds Organoplatinum Compounds Antineoplastic Agents Cisplatin Carboplatin DNA Adducts Antineoplastic Agents, Phytogenic Coordination Complexes Paclitaxel Cyclohexylamines Doxorubicin Palladium Antibiotics, Antineoplastic DNA Drug Carriers Chloroacetates Rhodium Cross-Linking Reagents Taxoids Plant Extracts Etoposide Prodrugs Intercalating Agents Camptothecin Bridged Compounds Deoxycytidine Ruthenium Topotecan Fluorouracil DNA, Neoplasm Antimetabolites, Antineoplastic Coated Materials, Biocompatible Organometallic Compounds Enzyme Inhibitors Glutathione Guanine Ellipticines P-Glycoprotein Anticarcinogenic Agents Tumor Suppressor Protein p53 Nanocapsules Vinblastine Ditiocarb Neoplasm Proteins Liposomes Osmium Platinum Antineoplastic Agents, Alkylating Nitrogen Compounds Polyethylene Glycols Topoisomerase I Inhibitors Iridium Radiation-Sensitizing Agents Ligands Topoisomerase Inhibitors Caspases Stilbenes Tubulin Modulators Endonucleases Graphite Annexin A3 Caspase 3 Multidrug Resistance-Associated Proteins Poly(ADP-ribose) Polymerases Thiepins Poly G Mitomycin DNA Topoisomerases, Type I Aziridines RNA, Small Interfering DNA Topoisomerases, Type II Anthracyclines Dioxoles Triterpenes Reactive Oxygen Species Xanthones Proto-Oncogene Proteins c-bcl-2 Cyclobutanes Gold Curcumin Polyglycolic Acid RNA, Messenger DNA-Binding Proteins Histone Deacetylase Inhibitors Polymers Iodized Oil Daunorubicin Angiogenesis Inhibitors Acridines Tungsten Naphthacenes Tetrahydroisoquinolines Drugs, Investigational Biological Products Naphthoquinones Chelating Agents Indazoles Oligonucleotides Noscapine Piperidones Amines Buthionine Sulfoximine Tetrazolium Salts Indoles Benzoquinones Pyridines Cation Transport Proteins ATP-Binding Cassette Transporters Sesquiterpenes Porphyrins

Analytical, Diagnostic and Therapeutic Techniques and Equipment58

Drug Screening Assays, Antitumor Inhibitory Concentration 50 Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Embolization, Therapeutic Drug Delivery Systems Drug Carriers Drug Design Treatment Outcome Spectrophotometry, Atomic Drug Administration Schedule Drug Evaluation, Preclinical Electrodes Radioallergosorbent Test Equipment Design Neoplasm Transplantation Neoplasms, Experimental Nanocapsules Models, Molecular Combined Modality Therapy Clinical Trials as Topic Drug Evaluation Transplantation, Heterologous Phytotherapy Blotting, Western Electroplating Magnetic Resonance Spectroscopy Area Under Curve Molecular Targeted Therapy Electrochemical Techniques Disease-Free Survival Flow Cytometry Infusions, Intravenous Survival Analysis Administration, Oral Models, Biological Clinical Trials, Phase I as Topic Metabolic Clearance Rate Tumor Stem Cell Assay Equipment Failure Analysis Chromatography, High Pressure Liquid Tumor Burden Melanoma, Experimental Clinical Trials, Phase II as Topic Drug Discovery Hyperthermia, Induced Survival Rate Cerebral Angiography Skin Tests Reverse Transcriptase Polymerase Chain Reaction Transfection Crystallography, X-Ray Electrolysis Neoplasm Staging Materials Testing Salvage Therapy Prognosis Clinical Trials, Phase III as Topic

Phenomena and Processes41

Drug Resistance, Neoplasm DNA Adducts Apoptosis Inhibitory Concentration 50 Cell Survival Dose-Response Relationship, Drug Molecular Structure Cell Proliferation Drug Synergism Drug Resistance Cell Cycle DNA Damage Structure-Activity Relationship Gene Expression Regulation, Neoplastic DNA Repair Time Factors Stereoisomerism Cell Division Signal Transduction Nucleic Acid Conformation Molecular Conformation Kinetics Particle Size Drug Resistance, Multiple Cell Death Area Under Curve Base Sequence Tissue Distribution Cell Cycle Checkpoints Metabolic Clearance Rate Isomerism Drug Interactions Down-Regulation Cell Growth Processes Binding Sites Biotransformation Transfection Protein Binding Phosphorylation Enzyme Activation Mutation

Disciplines and Occupations7

Drug Design Nanomedicine Nanotechnology Drug Discovery Electrochemistry Pharmacogenetics Meteorology

Technology, Industry, Agriculture12

Nanoparticles Metallurgy Nanomedicine Coated Materials, Biocompatible Metal Nanoparticles Nanocapsules Liposomes Polyethylene Glycols Nanotechnology Polyglycolic Acid Polymers Nanostructures

Information Science3

Base Sequence Survival Rate Molecular Sequence Data

Health Care9

Treatment Outcome Clinical Trials as Topic Area Under Curve Disease-Free Survival Survival Analysis Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Survival Rate Clinical Trials, Phase III as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Platinum Compounds Organoplatinum Compounds Antineoplastic Agents Cisplatin Drug Screening Assays, Antitumor Carboplatin Cell Line, Tumor Ovarian Neoplasms Drug Resistance, Neoplasm Neoplasms DNA Adducts Antineoplastic Agents, Phytogenic Apoptosis Coordination Complexes Inhibitory Concentration 50 Paclitaxel Cell Survival Tumor Cells, Cultured Cyclohexylamines Antineoplastic Combined Chemotherapy Protocols Leukemia L1210 Xenograft Model Antitumor Assays Doxorubicin Neoplasms, Glandular and Epithelial Dose-Response Relationship, Drug Embolization, Therapeutic Palladium Mice, Nude Molecular Structure Cell Proliferation Antibiotics, Antineoplastic Drug Synergism Lung Neoplasms Drug Delivery Systems DNA Drug Resistance Drug Carriers Chloroacetates Rhodium Cross-Linking Reagents Taxoids Cell Cycle DNA Damage Intracranial Aneurysm Plant Extracts Etoposide Prodrugs Intercalating Agents Drug Design Camptothecin Structure-Activity Relationship Bridged Compounds Treatment Outcome Gene Expression Regulation, Neoplastic Spectrophotometry, Atomic Deoxycytidine Nanoparticles Ruthenium Drug Administration Schedule Topotecan Metallurgy Fluorouracil Carcinoma, Non-Small-Cell Lung Nanomedicine DNA Repair DNA, Neoplasm Colonic Neoplasms Antimetabolites, Antineoplastic Drug Evaluation, Preclinical Time Factors Coated Materials, Biocompatible Breast Neoplasms Organometallic Compounds Enzyme Inhibitors HCT116 Cells Stereoisomerism Electrodes Cell Division Metal Nanoparticles Glutathione Guanine Radioallergosorbent Test Ellipticines Equipment Design P-Glycoprotein Neoplasm Transplantation Adenocarcinoma Neoplasms, Experimental Anticarcinogenic Agents Tumor Suppressor Protein p53 Signal Transduction Nanocapsules Models, Molecular Leukemia P388 Vinblastine Combined Modality Therapy Nucleic Acid Conformation Molecular Conformation Clinical Trials as Topic Kinetics

No FAQ available that match "platinum containing anticancer"